Use of virtual reality for symptom management in solid-tumor patients with implications for primary brain tumor research: a systematic review
Nicole M Leggiero 1, Terri S Armstrong 1, Mark R Gilbert 1, Amanda L King 1Affiliations expand
- PMID: 33014388
- PMCID: PMC7516123 (available on 2021-03-28)
- DOI: 10.1093/nop/npaa012
Abstract
Background: Primary brain tumors (PBTs) remain incurable, with a typically poor prognosis and significant symptom burden for patients. Virtual reality (VR) can potentially alleviate some of the negative aspects of illness by allowing individuals to escape to environments where they can experience more positive thoughts and emotions. Given promising findings for VR use in other clinical populations, there is increasing interest to use VR for symptomatic improvement in oncology patients. The purpose of this review was to analyze the literature of VR-related interventions for symptom management in adult PBT and other solid-tumor patients, which will guide development of future VR interventions in these populations.
Methods: A systematic search of EMBASE, PubMed, Scopus, and Web of Science was performed using PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines with predefined eligibility criteria. Thirteen studies met the inclusion criteria and were selected for review.
Results: Findings showed promising evidence that VR can improve anxiety for solid-tumor patients, with mixed results reported for pain, distress, depression, and mood. There was significant heterogeneity in methodological approaches across the literature and the majority of studies were underpowered and lacked rigorous study designs. Qualitative findings demonstrated a high degree of participant satisfaction with VR use, with very few adverse side effects reported.
Conclusions: Findings from this review suggest that VR can be used as an innovative delivery system for targeted interventions to improve symptoms in PBTs and other solid-tumor patient populations, though additional well-designed clinical trials are needed to better establish its efficacy.
Keywords: cancer; chemotherapy; glioma; neoplasm; tumors; virtual reality.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
- The Clinical Utility of Virtual Reality in Neurorehabilitation: A Systematic Review.Massetti T, da Silva TD, Crocetta TB, Guarnieri R, de Freitas BL, Bianchi Lopes P, Watson S, Tonks J, de Mello Monteiro CB.J Cent Nerv Syst Dis. 2018 Nov 27;10:1179573518813541. doi: 10.1177/1179573518813541. eCollection 2018.PMID: 30515028 Free PMC article. Review.
- Virtual Reality Technology for Pain and Anxiety Management among Patients with Cancer: A Systematic Review.Ahmad M, Bani Mohammad E, Anshasi HA.Pain Manag Nurs. 2020 May 15:S1524-9042(20)30116-8. doi: 10.1016/j.pmn.2020.04.002. Online ahead of print.PMID: 32423641 Review.
- Virtual reality simulation training for health professions trainees in gastrointestinal endoscopy.Khan R, Plahouras J, Johnston BC, Scaffidi MA, Grover SC, Walsh CM.Cochrane Database Syst Rev. 2018 Aug 17;8(8):CD008237. doi: 10.1002/14651858.CD008237.pub3.PMID: 30117156 Free PMC article.
- The Effectiveness of Virtual Reality in Managing Acute Pain and Anxiety for Medical Inpatients: Systematic Review.Smith V, Warty RR, Sursas JA, Payne O, Nair A, Krishnan S, da Silva Costa F, Wallace EM, Vollenhoven B.J Med Internet Res. 2020 Nov 2;22(11):e17980. doi: 10.2196/17980.PMID: 33136055 Free PMC article. Review.
- Implementations of Virtual Reality for Anxiety-Related Disorders: Systematic Review.Oing T, Prescott J.JMIR Serious Games. 2018 Nov 7;6(4):e10965. doi: 10.2196/10965.PMID: 30404770 Free PMC article. Review.
